Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Multiple Myeloma × apixaban × Clear all

Phase

Phase NA 1 Phase 4 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Venous Thrombosis 2 Neoplasms 2 Venous Thromboembolism 1 Thrombosis 1 Pulmonary Embolism 1 Multiple Myeloma 1

Interventions

Cyclophosphamide 17 Cyclosporine 9 fludarabine phosphate 8 Peripheral Blood Stem Cell Transplantation 8 Exercise 8 Blood Specimen Collection 8 Whole-Body Irradiation 7 Dexamethasone 7 Antilymphocyte Serum 7 fludarabine 6 Standard of Care 6 Radiotherapy 6 Mycophenolic Acid 6 Filgrastim 6 Acupuncture Therapy 6 Palliative Care 5 Educational Status 5 Therapeutics 4 Surveys and Questionnaires 4 Psychiatric Rehabilitation 4 Practice Guidelines as Topic 4 Melphalan 4 Granulocyte Colony-Stimulating Factor 4 Etoposide 4 Busulfan 4 Behavior Therapy 4 pomalidomide 3 Thalidomide 3 Stem Cell Transplantation 3 Spiritual Therapies 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06474182 2025-09-25

ProApix

Centre Hospitalier Universitaire de Saint Etienne

Phase NA Recruiting

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡